Erratum to: PRISM II: an open-label study to assess effectiveness of dextromethorphan/quinidine for pseudobulbar affect in patients with dementia, stroke or traumatic brain injury

Hammond, Flora M.Alexander, David N.Cutler, Andrew J.D’Amico, StephenDoody, Rachelle S.Sauve, WilliamZorowitz, Richard D.Davis, Charles S.Shin, PaulLedon, FredYonan, CharlesFormella, Andrea E.Siffert, Joao2017-05-222017-05-222016-09-02Hammond, F. M., Alexander, D. N., Cutler, A. J., D’Amico, S., Doody, R. S., Sauve, W., … Siffert, J. (2016). Erratum to: PRISM II: an open-label study to assess effectiveness of dextromethorphan/quinidine for pseudobulbar affect in patients with dementia, stroke or traumatic brain injury. BMC Neurology, 16(1), 160. http://doi.org/10.1186/s12883-016-0679-zhttps://hdl.handle.net/1805/12661en-USAttribution-NonCommercial-NoDerivs 3.0 United StatesCorrectionsErrorsY-axisErratum to: PRISM II: an open-label study to assess effectiveness of dextromethorphan/quinidine for pseudobulbar affect in patients with dementia, stroke or traumatic brain injuryArticle